Get the Stockscreener App
8.03
1.47%
-0.12
After Hours:
8.03
Avadel Pharmaceuticals Plc stock is traded at $8.03, with a volume of 1.10M.
It is down -1.47% in the last 24 hours and down -9.16% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$8.15
Open:
$8.1
24h Volume:
1.10M
Relative Volume:
0.91
Market Cap:
$746.95M
Revenue:
$47.56M
Net Income/Loss:
$-156.83M
P/E Ratio:
-4.388
EPS:
-1.83
Net Cash Flow:
$-127.98M
1W Performance:
+12.62%
1M Performance:
-9.16%
6M Performance:
-42.31%
1Y Performance:
-55.36%
1-Day Range:
$7.81
$8.15
1-Week Range:
$7.00
$8.22
52-Week Range:
$6.38
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
8.03 | 746.95M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Alliancebernstein L.P. Boosts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience - TradingView
Equities Analysts Offer Predictions for AVDL Q1 Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q2 Earnings - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Could Be Less Than A Year Away From Profitability - Yahoo Finance
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Set To Breakeven - simplywall.st
Vanguard Group Inc. Buys 90,147 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Needham & Company LLC Reiterates Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Announces Grant Of Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock Position Decreased by Corebridge Financial Inc. - Defense World
Brokerages Set Avadel Pharmaceuticals plc (NASDAQ:AVDL) Price Target at $19.88 - The AM Reporter
Avadel reports steady demand and patent lawsuits By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals updates at healthcare conference By Investing.com - Investing.com South Africa
Avadel Highlights Improved Demand for LUMRYZ at Conference - TipRanks
Avadel Pharmaceuticals updates at healthcare conference - Investing.com
Avadel Pharmaceuticals Projects 'Sustainable' Positive Cash Flow in 2025 - MarketScreener
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference - The Manila Times
Avadel reports steady demand and patent lawsuits - Investing.com
KLP Kapitalforvaltning AS Purchases New Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Commonwealth Equity Services LLC - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of “Buy” by Analysts - Defense World
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights - Investing.com
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Analyzing Avadel Pharmaceuticals plc (AVDL) After Recent Trading Activity - Knox Daily
HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World
Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com
Avadel Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire
What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World
What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):